Ceramic Implants vs. Root Canals for Health & Longevity

Evidence Review created on 04/28/2026 using AI4L / Opus 4.7

Also known as: Zirconia Implants vs. Endodontic Therapy, Metal-Free Implants vs. Root Canal Treatment, Ceramic Dental Implants vs. RCT, Zirconium Dioxide Implants vs. Endodontic Treatment

Motivation

When a tooth becomes severely infected at the root, two divergent paths are typically offered: a root canal (endodontic therapy), which removes the infected pulp and seals the dead but retained tooth in place, or extraction followed by replacement, increasingly with a ceramic (zirconia) implant rather than the long-standard titanium screw. The choice is genuinely contested. Endodontic literature presents root canal as conservative and tooth-preserving with strong long-term survival data; a biological-dentistry community argues that retained dead teeth harbor anaerobic bacteria and inflammatory signals with consequences extending beyond the mouth.

The disagreement matters for longevity-oriented adults because oral inflammation is now linked in long-term population studies to cardiovascular risk and blood-sugar control. Ceramic implants, available in clinical use since the late 2000s, have accumulated multi-year survival data approaching that of titanium and avoid metal hypersensitivity concerns.

This review examines the comparative evidence for retaining a non-vital tooth via root canal versus extracting and replacing it with a ceramic implant — the relevant clinical outcomes, the systemic-health signal, the procedural risks of each path, and the distinct interpretive lenses applied by conventional and biological dentistry.

Benefits - Risks - Protocol - Conclusion

Grokipedia

Root canal treatment - Grokipedia

A general-encyclopedia overview of endodontic therapy, covering procedure indications, technique, success rates, and historical context — useful for orienting readers to the conventional clinical understanding before considering biological-dentistry critiques.

No dedicated article on ceramic dental implants or zirconia implants was found on grokipedia.com as of April 2026.

Examine

No dedicated article on ceramic dental implants or root canal treatment was found on examine.com as of April 2026. Examine.com does not typically cover surgical dental procedures, focusing instead on dietary supplements and nutrition.

ConsumerLab

No dedicated article on ceramic dental implants or root canal treatment was found on consumerlab.com as of April 2026. ConsumerLab focuses on independent quality testing of supplements and consumer health products and does not cover surgical or restorative dental procedures.

Systematic Reviews

This section summarizes the highest-quality systematic reviews and meta-analyses comparing ceramic implant and endodontic outcomes, including their systemic-health effects.

Clinical outcomes of zirconia implants: a systematic review and meta-analysis - Mohseni et al., 2023

A 2023 meta-analysis of 25 studies covering 4,017 zirconia implants in 2,083 patients reporting a 10-year cumulative survival rate of 95.1%, with 172 implant failures occurring at a mean of 12 months. Mean marginal bone loss ranged from 0.63 to 2.06 mm over up to 132 months — establishing that contemporary ceramic implants achieve long-term survival comparable to titanium.
Survival and Success of Zirconia Compared with Titanium Implants: A Systematic Review and Meta-analysis - Padhye et al., 2023

A 2023 Queen Mary University of London systematic review identifying head-to-head RCT (randomized controlled trial) data (199 implants total) showing no statistically significant difference in 12-month survival between zirconia and titanium implants and a higher pink-aesthetic score for zirconia — the most direct comparative evidence currently available.
The Impact of Cardiovascular Disease and Endodontic Outcome: A Systematic Review of Longitudinal Studies - Aminoshariae et al., 2020

A systematic review of longitudinal cohorts finding that patients with cardiovascular disease showed a 67% higher risk of negative endodontic outcomes (RR (relative risk) 1.67, 95% CI (confidence interval) 1.53–1.81), with moderate GRADE (Grading of Recommendations Assessment, Development and Evaluation, an evidence-quality rating framework) confidence — establishing a bidirectional clinical link between systemic inflammatory disease and root canal prognosis relevant to longevity-oriented adults. Note that this systematic review and the 2024 follow-up below are published in the Journal of Endodontics, the official journal of an endodontist professional association whose members earn revenue from preserving (rather than extracting) teeth.
Tooth Loss is a Risk Factor for Cardiovascular Disease Mortality: A Systematic Review with Meta-analyses - Aminoshariae et al., 2024

A 2024 meta-analysis of 12 cohort studies finding that being edentulous (toothless) or having fewer than 10 teeth predicted cardiovascular mortality (HR (hazard ratio) 1.66, 95% CI 1.32–2.09), with an adjusted-confounder HR of 1.52 — reinforcing that tooth retention has cardiovascular implications, a finding the endodontic establishment uses to defend root canal therapy over extraction.
Ceramic Dental Implants: A Systematic Review and Meta-analysis - Neugebauer et al., 2023

A PRISMA-compliant (Preferred Reporting Items for Systematic Reviews and Meta-Analyses, the standard reporting guideline) meta-analysis of 11 studies on one-piece ceramic implants reporting marginal bone level changes of 0.94 ± 0.11 mm at 1 year, 1.20 ± 0.14 mm mid-term, and 1.24 ± 0.16 mm long-term, with osseointegration comparable to titanium — confirming clinical maturity of the ceramic implant platform.

Mechanism of Action

The two interventions represent fundamentally different biological strategies for managing a non-vital or severely compromised tooth.

Root canal treatment (endodontic therapy) removes infected or necrotic pulp tissue from the tooth’s internal canal system, mechanically and chemically debrides the canal with antimicrobial irrigants (typically sodium hypochlorite and EDTA, ethylenediaminetetraacetic acid, a chelator), and seals the canal space with an inert filling (gutta-percha and sealer) to prevent reinfection. The retained tooth structure preserves bone volume and proprioception (the sense of tooth position and chewing force) provided by the periodontal ligament. The principal mechanistic concern raised by biological dentistry is that the dentinal tubule network — totaling several kilometers of microscopic channels per tooth — cannot be fully sterilized; surviving anaerobic bacteria are hypothesized to produce thioethers and other toxins, sustain a low-grade systemic inflammatory burden, and seed bacteremia (transient bacteria in the bloodstream) during chewing.

Ceramic dental implants replace the entire tooth-and-root unit with a zirconium-dioxide (ZrO₂) screw, typically yttria-stabilized tetragonal zirconia polycrystal (Y-TZP), surgically placed into the alveolar bone after extraction. Osseointegration — the direct structural and functional connection between bone and implant surface — proceeds via a ceramic-bone interface that, unlike titanium, releases no metallic ions, has lower bacterial affinity due to surface charge and hydrophilicity, and elicits less peri-implant soft-tissue inflammation in preclinical models. The mechanistic case is that complete removal of the infected tooth, periodontal ligament, and any granulomatous tissue (combined with extraction-site decontamination) eliminates the chronic anaerobic reservoir, while the zirconia surface itself is biologically inert and aesthetically tooth-colored.

Where the mechanistic narratives diverge: conventional endodontics holds that modern obturation (canal sealing) plus coronal seal effectively contain residual bacteria, that the recently demonstrated reductions in hsCRP (high-sensitivity C-reactive protein, a general marker of systemic inflammation), asymmetric dimethylarginine (a marker of vascular dysfunction), and matrix metalloprotease-2 (an enzyme involved in tissue inflammation and remodeling) after successful root canal treatment counter the focal-infection critique, and that retained tooth structure preserves bone and function better than any artificial replacement. Biological dentistry counters that asymptomatic root-canal-treated teeth still harbor recoverable anaerobic species, that dentinal-tubule sterilization remains incomplete by every available technique, and that the appropriate comparator is not “untreated infected tooth” but “complete extraction with thorough socket debridement plus ceramic implant.”

Historical Context & Evolution

Endodontic therapy and the focal-infection critique have a deeply intertwined history.

The procedure now called root canal treatment evolved from 19th-century pulp extirpation techniques. In the early 20th century, Weston A. Price — at one point research director of the National Dental Association (precursor to the ADA, the American Dental Association) — published 25 years of investigations, including the two-volume 1923 work Dental Infections, Oral and Systemic and Dental Infections and the Degenerative Diseases, concluding that bacteria sequestered in dentinal tubules of pulpless teeth could disseminate systemically and cause or aggravate degenerative diseases including arthritis, kidney disease, and heart disease. Price’s primary methodology included extracting endodontically treated teeth from patients with systemic disease, surgically implanting fragments under the skin of laboratory rabbits, and observing whether the rabbits developed conditions paralleling those of the human donors; he reported reproducible transfer of arthritis, nephritis, and cardiac inflammation in many of these animal experiments. Price’s work was a leading expression of the broader “focal infection theory” that drove widespread tooth extraction during that era. By the 1930s and 1940s, the theory was set aside in mainstream medicine and dentistry following critiques that Price’s microbiological methods (predating modern anaerobic culture and molecular techniques) could have over-attributed pathogenic significance to recovered organisms, and on observations that systemic disease did not reliably resolve after extraction in subsequent clinical series; root canal therapy was rehabilitated and became standard care. The strength and reproducibility of the original Price findings continues to be discussed across both mainstream and biological-dentistry literatures.

Modern endodontics emerged in the second half of the 20th century with the development of nickel-titanium rotary instrumentation, sodium hypochlorite irrigation, and improved obturation materials. Long-term cohort data accumulated showing 86–93% tooth survival at 8–10 years post-treatment.

The focal-infection question was not, however, fully closed. From the 1990s onward, polymerase-chain-reaction and 16S rRNA (16S ribosomal RNA, a genetic marker used to identify bacterial species) sequencing detected viable anaerobic bacteria in apparently asymptomatic root-canal-treated teeth. Cohort and biomarker studies linked apical periodontitis to elevated hsCRP, IL-6 (interleukin-6, a pro-inflammatory cytokine), IL-8 (interleukin-8, a pro-inflammatory cytokine), and asymmetric dimethylarginine, and successful endodontic treatment was shown in 2023–2025 metabolomic and biomarker work to reduce these markers and improve glycemic indices. The position framed by the King’s College reviews is that the focal-infection theory in its original Price-era form is no longer held in its broadest form, while low-grade systemic inflammation from untreated or persistent endodontic infection is now understood as real and clinically meaningful — narrowing rather than closing the original question.

Ceramic implants entered clinical use in Europe in the 2000s, received FDA clearance in 2007, and accumulated 10-year survival data exceeding 95% by the early 2020s. The biological dentistry movement (organized in part through the IAOMT, whose member practitioners earn revenue from the extraction-plus-implant pathway it advocates) re-articulated a Price-derived position arguing that zirconia implants — a clinical option Price did not have — make extraction the preferable response to a non-vital or chronically infected tooth. The endodontic establishment (through professional associations whose members earn revenue from preserving rather than extracting teeth) continues to advocate root canal preservation, supported by newer biomarker evidence that successful treatment reduces systemic inflammation.

Expected Benefits

High 🟩 🟩 🟩

Tooth Retention with Bone and Proprioception Preservation (Root Canal)

Root canal therapy preserves the natural tooth root, periodontal ligament, and surrounding alveolar bone, maintaining proprioception (the sensory feedback that modulates chewing force and tooth position). Avoiding extraction prevents the immediate ~25% buccal-lingual bone width loss that typically follows tooth removal in the first year and may avoid implant-related complications. The evidence basis is multiple long-term cohort studies summarized in Setzer & Kim’s J Dent Res systematic review (2014).

Magnitude: Pooled survival rates of endodontically treated teeth are 92–97% at 6 years and 86–93% at 8–10 years, comparable to single-tooth implants over equivalent follow-up.

Long-Term Survival of Ceramic Implants (Ceramic Implant)

Contemporary one-piece zirconia implants achieve a 10-year cumulative survival rate of 95.1% per the Mohseni et al. 2023 meta-analysis (4,017 implants, 25 studies), with most failures occurring within the first 12 months and stabilizing thereafter. Marginal bone loss is modest (0.94 mm at 1 year, 1.24 mm long-term) and survival is statistically equivalent to titanium implants in head-to-head 12-month RCT data.

Magnitude: 10-year survival ~95%; 5-year survival ~96–97% in single-tooth restorations.

Reduction in Systemic Inflammatory Burden (Both, When Successful)

Successful resolution of the underlying infection — whether by complete root canal treatment with apical healing or by extraction plus ceramic implant — reduces serum hsCRP, asymmetric dimethylarginine, and matrix metalloprotease-2 in 2-year follow-up data (Al-Abdulla et al. 2023). A 2025 longitudinal metabolomic study (Zhang et al., King’s College) found improvements in glucose, lipid, and branched-chain amino acid profiles after successful endodontic treatment of apical periodontitis.

Magnitude: hsCRP reductions of approximately 30–50% at 2 years post-treatment in successfully healed cases; significant favorable shifts in 24 of 44 measured serum metabolites.

Medium 🟩 🟩

Avoidance of Metal Hypersensitivity and Galvanic Effects (Ceramic Implant)

Ceramic implants release no metal ions and eliminate the small but documented risk of titanium hypersensitivity reported as gingival hyperplasia, dermatitis, and oral lichenoid reactions in case series. They also eliminate the theoretical galvanic interaction between dissimilar metals (e.g., titanium implants adjacent to gold or amalgam restorations). Evidence basis: Javed et al. 2013 systematic review and subsequent case-series data, with prevalence estimates of 0.6–6% titanium-positive patch test results in implant patients.

Magnitude: Eliminates a 0.6–6% baseline titanium hypersensitivity prevalence; magnitude of clinical benefit depends on individual susceptibility.

Lower Bacterial Affinity and Reduced Peri-Implant Inflammation (Ceramic Implant)

Zirconia surfaces accumulate less plaque and exhibit lower bacterial colonization than titanium in vitro and in early clinical comparisons, with histological data showing reduced inflammatory infiltrates around ceramic implants in cases of peri-implant disease. The 2025 Shrivastava et al. systematic review concluded zirconia is associated with lower peri-implantitis (inflammatory destruction of supporting bone around an implant) incidence than titanium, though long-term head-to-head data remain limited.

Magnitude: Quantitative head-to-head peri-implantitis incidence data are limited; reductions in surface biofilm mass on the order of 20–40% in vitro.

Aesthetic Outcomes in the Visible Zone (Ceramic Implant)

Ceramic implants are tooth-colored and avoid the gray gingival margin discoloration that titanium can produce in patients with thin biotype gingiva. Pink-aesthetic-score data in head-to-head RCTs show statistically higher scores for zirconia (10.3–11.4) vs. titanium (8.1–11.6).

Magnitude: Pink Esthetic Score advantage of ~1–2 points (out of 14) over titanium in anterior placements.

Low 🟩

Cost-Effectiveness Over Lifetime (Root Canal)

Root canal therapy costs $700–$2,500 in the U.S. versus $4,500–$8,500 for a ceramic implant plus crown, and avoids the cumulative costs of crown replacement on the implant abutment over a lifetime. While not the focus of this review, lifetime cost differences are large enough to factor into accessibility for many patients.

Magnitude: Initial cost differential of ~$3,000–$6,000 in favor of root canal therapy.

Speculative 🟨

Reduction in Chronic Disease Burden via Elimination of Anaerobic Reservoir (Ceramic Implant After Extraction)

The biological-dentistry hypothesis holds that complete removal of the chronically infected tooth — and replacement with an inert ceramic implant — reduces lifetime exposure to circulating endotoxins and anaerobic metabolites, with proposed downstream reductions in cardiovascular events, autoimmune flares, and chronic fatigue. No controlled studies directly test this comparison; the basis is mechanistic, anecdotal clinical case series from biological-dentistry practices, and indirect inference from observational links between apical periodontitis and systemic inflammatory markers.

Improved Glycemic and Cardiovascular Markers Beyond What Successful Root Canal Achieves (Ceramic Implant After Extraction)

An extension of the prior speculative benefit: that extraction plus ceramic implant produces larger reductions in hsCRP, IL-6, and HbA1c (glycated hemoglobin, a 3-month average blood-sugar marker) than a successful root canal because residual dentinal-tubule bacteria are eliminated entirely. No controlled head-to-head trial has been performed; the basis is mechanistic and the implicit comparison is between “successful root canal” (which already shows improvement) and “complete eradication.”

Benefit-Modifying Factors

Pre-existing cardiovascular disease: Patients with established cardiovascular disease have a 67% higher risk of negative endodontic outcomes (Aminoshariae 2020 meta-analysis), shifting the benefit/risk calculation toward extraction-and-implant in that subgroup if the tooth would require complex retreatment.
Tooth restorability: A tooth with severe structural loss (less than 2 mm of healthy ferrule, vertical root fracture, perforation, or large periapical lesion) has materially lower root canal success rates and a meaningfully better expected outcome with extraction plus implant. The structural status of the residual tooth is the single largest benefit modifier for root canal therapy.
Bone volume at the candidate implant site: Adequate alveolar bone width and height predict ceramic implant success; insufficient bone may require grafting, lengthening treatment time and reducing the benefit margin of choosing implant over root canal.
Baseline biomarker levels: Baseline 25-hydroxyvitamin D below ~30 ng/mL has been associated with reduced bone-healing capacity for both extraction sockets and periapical repair, lowering the benefit margin for either intervention until corrected. Baseline hsCRP above ~3 mg/L signals elevated systemic inflammatory burden and a smaller incremental benefit from either procedure until underlying inflammation is addressed.
Diabetes mellitus: Both endodontic outcomes and implant osseointegration are modestly impaired by uncontrolled hyperglycemia; HbA1c above 8% is associated with reduced success rates of either intervention.
Smoking and oral hygiene: Active smoking and poor oral hygiene reduce both root canal long-term success and implant osseointegration; the magnitude of the reduction is similar for both procedures, so the comparative benefit is largely preserved.
Sex-based considerations: No clinically meaningful sex-based difference in ceramic implant survival or root canal success has been established. Pregnancy is a relevant timing consideration for both.
Age-related considerations: Older adults have slower osseointegration and slower periapical healing. For ceramic implants in adults over 70, healing time is typically extended by 1–2 months. For root canal, calcified canals (more common with age) reduce success rates.
Genetic polymorphisms: Specific polymorphisms have not been validated as decisional factors in this comparison. Heterozygosity in interleukin-1 family genes (IL1A, IL1B — genes that encode interleukin-1 alpha and beta, pro-inflammatory signaling proteins driving the inflammatory response) has been associated with peri-implantitis risk in some studies, with effect sizes too small for clinical decision-making.

Potential Risks & Side Effects

High 🟥 🟥 🟥

Persistent or Recurrent Apical Infection After Root Canal (Root Canal)

Even technically successful root canal therapy fails to fully sterilize the dentinal tubule network in approximately 7–14% of cases at 8–10 years, manifesting as persistent or recurrent apical periodontitis (inflammation at the root tip). Failed root canals typically require retreatment, apical surgery, or eventual extraction. Evidence basis: long-term cohort studies summarized in Setzer & Kim 2014 and clinical biomarker work showing residual elevation of inflammatory markers in some treated patients.

Magnitude: ~7–14% retreatment or extraction rate at 8–10 years.

Implant Failure Including Early Osseointegration Failure (Ceramic Implant)

Approximately 4–5% of zirconia implants fail within 10 years per Mohseni 2023; most failures occur within the first 12 months due to failed osseointegration, with a smaller subset due to implant fracture (particularly in narrow-diameter one-piece implants). Failure typically requires implant removal, bone grafting, and a second implant attempt or alternative restoration. Evidence basis: meta-analysis of 4,017 ceramic implants.

Magnitude: ~5% 10-year failure rate (95.1% survival in Mohseni 2023).

Medium 🟥 🟥

Vertical Root Fracture and Crown Failure of Endodontically Treated Teeth (Root Canal)

Endodontically treated teeth become more brittle over time due to dehydration of dentin and loss of pulpal blood supply, with vertical root fractures occurring in 2–5% of treated teeth — typically requiring extraction. Post-and-core restorations and full-coverage crowns mitigate but do not eliminate this risk. Evidence basis: clinical cohort studies and prosthodontic literature.

Magnitude: 2–5% lifetime vertical root fracture rate; an additional 5–10% experience coronal restoration failure necessitating retreatment.

Peri-Implantitis and Marginal Bone Loss (Ceramic Implant)

Ceramic implants can develop peri-implantitis at lower but non-zero rates compared with titanium. Mean marginal bone loss of 0.94 mm at 1 year and 1.24 mm long-term is reported by Neugebauer 2023. Risk factors include poor oral hygiene, smoking, history of periodontitis, and improper occlusal loading.

Magnitude: Long-term marginal bone loss approximately 1.0–1.5 mm; clinical peri-implantitis incidence estimated at lower than titanium’s 12–22%, with sparser comparative data.

Surgical Risks of Extraction and Implant Placement (Ceramic Implant)

Implant placement carries surgical risks including inferior alveolar nerve injury (in posterior mandibular sites; <1% in expert hands), maxillary sinus perforation in upper posterior placements, postoperative infection, and the rare but serious complication of jawbone osteonecrosis at the surgical site. These risks are absent with root canal therapy.

Magnitude: Nerve injury <1%; sinus perforation <2%; postoperative infection 1–4%.

Low 🟥

Bacteremia and Transient Inflammatory Spikes During Procedure (Both)

Both root canal therapy and tooth extraction produce transient bacteremia detectable in blood cultures within minutes of the procedure. In healthy adults this is clinically silent; in patients with prosthetic joints or specific cardiac conditions, antibiotic prophylaxis is sometimes recommended per AHA (American Heart Association) guidelines (the AHA is a cardiology professional and advocacy organization whose guideline-setting influences cardiology standards of care).

Magnitude: Bacteremia detected in 30–70% of patients post-procedure; clinically relevant infectious endocarditis (bacterial infection of the heart’s inner lining) risk is rare (<1 per 100,000 procedures).

Implant Fracture Due to Material Brittleness (Ceramic Implant)

Zirconia is harder but more brittle than titanium and can fracture under high occlusal loads, particularly in narrow-diameter (≤3.5 mm) one-piece designs. Modern reinforced-zirconia formulations have reduced this risk to <1% per Mohseni 2023, but it remains a procedure-specific consideration absent from root canal alternatives.

Magnitude: Implant fracture rate <1% with current materials; 0.2% per SDS 2019 manufacturer assessment.

Speculative 🟨

Cavitation/Jawbone Osteonecrosis at Extraction Site (Ceramic Implant Path) ⚠️ Conflicted

Biological dentistry literature describes neuralgia-inducing cavitational osteonecrosis (NICO) — pockets of poorly healed, necrotic bone at past extraction sites — as a complication of inadequate socket debridement (notably failure to remove the periodontal ligament). Mainstream dentistry largely disputes the entity as a distinct clinical syndrome. The evidence basis is biological-dentistry case series and the IAOMT position paper; controlled epidemiological data are essentially absent.

Tooth Loss and Cardiovascular Mortality (Ceramic Implant Path)

The 2024 Aminoshariae meta-analysis showed that becoming edentulous or having fewer than 10 teeth is associated with elevated cardiovascular mortality (HR 1.66). Whether replacing an extracted tooth with a ceramic implant fully restores the cardiovascular-protective effect of the original tooth is not directly studied. The biological mechanism remains uncertain and likely reflects shared inflammatory or nutritional pathways rather than tooth loss per se.

Risk-Modifying Factors

Bruxism (tooth grinding): Heavy bruxism increases risk of zirconia implant fracture and of vertical root fracture in endodontically treated teeth. A nightguard reduces both risks; severe bruxism may favor titanium-implant alternatives over ceramic in posterior sites.
Smoking: Active smoking impairs both periapical healing and implant osseointegration. Smokers have 2–3× higher implant failure rates and meaningfully lower root canal success; cessation 4–8 weeks pre-procedure improves outcomes for either path.
Diabetes: HbA1c above 8% impairs healing for both procedures. Optimal glycemic control before either intervention is the single most actionable risk modifier.
Baseline biomarker levels: Baseline 25-hydroxyvitamin D below ~30 ng/mL is associated with delayed osseointegration and higher post-procedure complication rates; baseline hsCRP above ~3 mg/L flags elevated systemic inflammation that increases peri-implant and persistent-periapical-inflammation risk for either pathway.
Bone quality: Type IV (very soft) maxillary bone is associated with reduced ceramic implant primary stability and higher early failure rates; type I dense mandibular bone reduces this risk substantially.
Periodontal status: Pre-existing periodontitis predicts both peri-implantitis (around an implant) and persistent apical periodontitis (after root canal). Periodontal stabilization should precede either intervention.
Sex-based considerations: Postmenopausal women on bisphosphonates or denosumab face an elevated medication-related osteonecrosis risk that complicates extraction more than root canal — favoring tooth retention in that population.
Age-related considerations: Older adults heal more slowly from both procedures; calcified pulp canals reduce root canal success in adults over 60. Adults over 70 with multiple comorbidities may favor the less-invasive root canal where the tooth is salvageable.
Genetic polymorphisms: IL-1 family polymorphisms have been associated with peri-implantitis susceptibility in some studies, with effect sizes too small for routine pre-procedure genotyping.

Key Interactions & Contraindications

Bisphosphonates and denosumab (RANKL inhibitor, a drug that blocks bone breakdown by inhibiting the RANK ligand pathway): Drugs in the antiresorptive class (a drug class that slows bone resorption — including alendronate, ibandronate, zoledronate, denosumab) elevate the risk of medication-related osteonecrosis of the jaw following extraction or implant placement. Severity: caution to absolute contraindication depending on cumulative IV dose. Consequence: post-extraction non-healing osteonecrosis. Mitigation: drug holiday discussion with prescribing physician; root canal often preferred over extraction in active or recent users.
Anticoagulants and antiplatelets: Warfarin, direct oral anticoagulants (apixaban, rivaroxaban), and dual antiplatelet therapy (aspirin plus clopidogrel) increase post-extraction bleeding. Severity: caution. Consequence: prolonged hemorrhage, hematoma. Mitigation: typically not discontinued for routine extraction or implant placement; INR (international normalized ratio, a measure of blood-clotting time) check for warfarin patients (target ≤3.5).
Over-the-counter (OTC) NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) and analgesics (ibuprofen, naproxen, OTC aspirin, acetaminophen): Chronic high-dose NSAID use mildly increases bleeding risk at extraction and may modestly delay osseointegration in animal data. Acetaminophen has minimal bleeding risk. Severity: monitor (NSAIDs); minimal (acetaminophen). Consequence: prolonged hemorrhage. Mitigation: pause NSAIDs 3–5 days pre-procedure where the indication permits; acetaminophen is the standard post-procedure analgesic.
Supplements affecting bleeding (fish oil/omega-3, vitamin E, garlic, Ginkgo biloba, ginger): Several common supplements have antiplatelet activity and can additively increase peri-procedural bleeding when combined with anticoagulants or antiplatelets. Severity: caution. Consequence: prolonged hemorrhage. Mitigation: discontinue 7–10 days before extraction or implant surgery and resume after initial wound closure.
Supplements with potentially additive healing or anti-inflammatory effects (vitamin D, vitamin K2, vitamin C, collagen peptides, curcumin, omega-3): These supplements may support post-procedure bone healing and reduce inflammation, paralleling the protocol-recommended micronutrient targets. Severity: minimal. Consequence: potentially supportive of recovery. Mitigation: not a contraindication; coordinate with prescribing clinician for any high-dose regimens.
Bevacizumab and other antiangiogenics: Increase risk of impaired wound healing and osteonecrosis at extraction or implant sites. Severity: caution. Consequence: non-healing wound. Mitigation: timing relative to oncology dosing in coordination with treating oncologist.
Immunosuppressants and chronic corticosteroids: Higher rates of peri-implantitis and impaired periapical healing. Severity: caution. Consequence: implant loss or persistent infection. Mitigation: minimize dose; defer elective implant until immunosuppression reduced where possible.
Recent radiation therapy to head/neck: Substantial risk of osteoradionecrosis (radiation-induced death of jawbone tissue) at extraction sites. Severity: relative contraindication for extraction. Consequence: chronic non-healing bone exposure. Mitigation: hyperbaric oxygen protocols pre- and post-extraction; root canal often strongly preferred.
Active infectious endocarditis history or prosthetic heart valve: AHA guidelines (issued by the American Heart Association, a cardiology professional and advocacy organization whose guideline-setting influences cardiology standards of care) advise antibiotic prophylaxis (amoxicillin 2 g 1 hour pre-procedure or clindamycin in penicillin allergy) for both extraction and root canal. Severity: caution. Consequence: bacteremia-mediated endocarditis. Mitigation: prophylaxis regimen.
Prosthetic joint replacement: The ADA-AAOS 2015 update (a joint statement from the American Dental Association and the American Academy of Orthopaedic Surgeons, both professional associations whose members earn revenue from the procedures they govern) advises that antibiotic prophylaxis is no longer routine for dental procedures; case-by-case decision based on patient risk factors.
Populations to avoid implant placement: Active uncontrolled diabetes (HbA1c >9%), active malignancy at the implant site, recent intravenous bisphosphonate use within 6 months for high-risk indications, active heavy smoking (>20 cigarettes/day) without willingness to quit pre-procedure, and skeletal immaturity (under age 18) are relative-to-absolute contraindications for ceramic implant placement.
Populations to avoid root canal preservation: Vertical root fracture (extraction is the only reliable option), large periapical lesion with extensive bone destruction, perforation that cannot be sealed, and severely compromised remaining tooth structure (less than 2 mm ferrule height) — in these cases extraction-plus-implant is the more reliable path.

Risk Mitigation Strategies

Comprehensive pre-procedure imaging with CBCT (cone-beam computed tomography): Practitioners on both sides of the comparison routinely perform a 3D CBCT scan before either intervention to identify root anatomy, periapical pathology, prior cavitation lesions at the candidate implant site, and bone-volume adequacy. The reported effect is fewer intra-procedural surprises and lower failure rates across both pathways.
Glycemic optimization to HbA1c below 7% pre-procedure: In clinical practice, HbA1c below 7% (and, in some integrative protocols, below 6.5%) for at least 3 months before either ceramic implant or complex endodontic procedure is associated with improved healing and reduced post-procedure infection rates.
Smoking cessation 4–8 weeks pre- and 8 weeks post-procedure: Smoking cessation in this window has been associated with approximately 2–3× lower ceramic implant failure rates and improved periapical healing in root canal cases — directly addressing the higher failure rates documented in active smokers.
Antibiotic prophylaxis where indicated: Amoxicillin 2 g 1 hour pre-procedure (or clindamycin 600 mg in penicillin-allergic patients) for patients with prosthetic heart valves, prior endocarditis, or specific cardiac conditions per AHA guidance — addresses bacteremia-mediated endocarditis risk during either procedure.
Use of dental dam during root canal: Strict isolation with rubber dam reduces salivary bacterial contamination of the canal during instrumentation, improving long-term sterility and reducing persistent infection risk.
Sodium hypochlorite irrigation with ultrasonic activation: Activated NaOCl (sodium hypochlorite) at 5–6% concentration plus EDTA improves dentinal-tubule bacterial reduction relative to passive irrigation and addresses the principal mechanistic concern of incomplete sterilization.
Complete socket debridement and periodontal-ligament removal at extraction: Thorough mechanical removal of the periodontal ligament and granulation tissue from the extraction socket, often with adjunct ozone or laser decontamination per biological-dentistry protocols, addresses the cavitation/NICO risk and prepares an optimal site for ceramic implant placement.
Bone grafting at extraction or implant placement where indicated: Socket preservation with allograft, xenograft, or autologous bone at the time of extraction maintains alveolar ridge dimensions for future ceramic implant placement and reduces the need for later, more invasive grafting.
Provisional immediate temporization vs. delayed loading decision: Submerged healing for ceramic implants (3–6 months in maxilla, 2–4 months in mandible) reduces early loading failure compared with immediate loading, particularly for narrow-diameter one-piece designs prone to fracture.
Occlusal nightguard for bruxism: A flat-plane occlusal splint reduces overload-related failure of either endodontically treated teeth (vertical root fracture) or ceramic implants (zirconia fracture) in patients with documented or suspected bruxism.
Recall protocol with periapical and panoramic imaging: Annual periapical radiographs for 2 years post-procedure, then every 2–3 years, allow early detection of either persistent apical periodontitis or peri-implant bone loss.

Therapeutic Protocol

The following describes the standard protocols as practiced by leading clinicians on both sides of the comparison. Where the conventional and biological-dentistry approaches diverge, both are presented.

Initial diagnostic workup: Both approaches begin with periapical radiographs, pulp vitality testing (cold, electric pulp test), percussion and palpation testing, and increasingly CBCT 3D imaging. The decision tree branches at this point.
Conventional endodontic protocol (root canal preservation): This protocol — codified through the American Association of Endodontists (AAE) and informed by leading academic endodontists such as Frank Setzer (University of Pennsylvania) and Sadia Niazi (King’s College London) — uses local anesthesia, rubber-dam isolation, access cavity preparation, mechanical canal instrumentation with rotary nickel-titanium files to apical patency, irrigation with 5–6% sodium hypochlorite plus 17% EDTA (often ultrasonically activated), interappointment calcium hydroxide dressing if symptomatic, obturation with gutta-percha and bioceramic sealer, and full-coverage crown restoration within 2–4 weeks. Two visits typical; single-visit protocols acceptable for selected cases.
Biological-dentistry endodontic protocol: Popularized through IAOMT-affiliated clinicians such as Stuart Nunnally (Texas), Stuart Nunnally’s Center for Healing Dentistry, and Hal Huggins’s earlier work, some integrative practitioners decline to perform root canals at all and counsel extraction. Those who do perform endodontics typically add ozone gas irrigation, laser disinfection (Er:YAG or Nd:YAG), and bioceramic obturation, with stricter case selection — favoring extraction whenever the prognosis is doubtful.
Extraction-plus-ceramic-implant protocol (typical): Promulgated through Swiss Dental Solutions/SDS founder Ulrich Volz and CeraRoot’s Sammy Noumbissi, the protocol uses atraumatic extraction with periotomes, complete periodontal-ligament curettage, socket decontamination (often with ozone, hypochlorite irrigation, or laser), socket preservation grafting, and either immediate ceramic implant placement (where bone volume permits) or 3–4 month delayed placement after socket healing. One-piece ceramic implants are placed submerged or transmucosally; two-piece systems use a healing abutment. Restorative crown placement at 3–6 months post-implant.
Best time of day: Morning placement is often preferred for surgical procedures to allow same-day clinical observation and better fasting glucose status. Not a major efficacy modifier.
Half-life consideration: Not applicable to a procedure-based intervention. Implant osseointegration timeline is the analogous parameter: typically 3–6 months for full bone integration of zirconia.
Single vs. split dosing: Not applicable.
Genetic polymorphisms: Routine genotyping is not standard. IL-1 polymorphisms have weak associations with peri-implantitis but do not currently inform protocol selection.
Sex-based protocol differences: No protocol differences. Postmenopausal women on antiresorptive medication require special consideration (drug holiday discussion).
Age-related considerations: Older adults benefit from extended healing periods (4–6 months for ceramic implant osseointegration vs. 3–4 in younger adults). Calcified canals in older adults reduce root canal feasibility and may push the decision toward extraction.
Baseline biomarkers: Pre-procedure HbA1c (target <7%), 25-hydroxyvitamin D (target >40 ng/mL for bone healing), and CBC (complete blood count) should be in functional range for either elective ceramic implant placement or complex endodontic surgery.
Pre-existing health conditions: Active periodontitis must be controlled before either procedure. Cardiovascular disease, diabetes, and immunosuppression as discussed in earlier sections.

Discontinuation & Cycling

Lifelong vs. short-term: Both interventions are intended as definitive long-term solutions for the affected tooth. A successfully treated tooth or a successfully osseointegrated ceramic implant should function for decades.
Withdrawal effects: Not applicable. There is no pharmacological withdrawal phenomenon.
Tapering protocol: Not applicable.
Cycling consideration: Not applicable. However, ceramic-implant restorative crowns may need replacement at 10–20 year intervals due to wear of the crown material (independent of the implant body itself), and root-canal-treated teeth may require crown replacement on a similar schedule.
Failure pathway: When a root canal fails, the standard sequence is non-surgical retreatment, then apical surgery (apicoectomy), then extraction-plus-implant. When a ceramic implant fails, the standard sequence is implant removal, bone grafting, and a second implant attempt (titanium or ceramic) or alternative restoration.

Sourcing and Quality

Ceramic implant brands with longest clinical track record: Z-Systems (Switzerland; first two-piece zirconia bone-level implant), CeraRoot (Spain; in U.S. since 2011; reported 98% 15-year success), and Swiss Dental Solutions/SDS (Switzerland; reported 0.2% fracture rate). Each manufactures Y-TZP or reinforced-zirconia implants with documented long-term outcomes. Practitioner experience with the specific system is a stronger predictor of outcome than brand alone.
What to look for in a ceramic implant clinic: FDA-cleared zirconia implant systems, surgeon experience with at least 100+ ceramic placements, in-house CBCT imaging, and ideally membership in the IAOMT or affiliated biological-dentistry organizations for clinicians offering the integrative protocol.
Endodontic provider qualifications: Treatment by a board-certified endodontist (rather than general dentist) is associated with higher long-term success rates, particularly for molars and retreatment cases. The American Association of Endodontists offers a “Find an Endodontist” directory.
Imaging quality: CBCT (cone-beam computed tomography) is increasingly standard for both complex endodontic cases and implant planning. Lower radiation dose and higher resolution distinguish current-generation machines.
Restorative materials for the final crown: On a ceramic implant or post-endodontic tooth, the crown material (lithium disilicate, monolithic zirconia, or layered porcelain) materially affects long-term wear and fracture characteristics. Monolithic zirconia crowns currently offer the best balance of strength and aesthetics in posterior sites.

Practical Considerations

Time to effect: Root canal therapy provides immediate symptomatic relief from acute pulpal pain at the first appointment; full radiographic apical healing requires 6–24 months. Ceramic implant placement is followed by 3–6 months of osseointegration before final crown loading; full functional rehabilitation typically requires 4–8 months from extraction.
Common pitfalls: For root canal — rushing to single-visit treatment when symptomatic, inadequate apical seal, and failure to place a definitive crown promptly (a temporary filling left for months allows coronal microleakage and recontamination). For ceramic implants — inadequate site preparation, immediate loading of narrow-diameter one-piece designs, and failure to address bruxism prior to placement.
Regulatory status: Both procedures are FDA-regulated and standard of care. Ceramic implants have been FDA-cleared in the United States since 2007; specific systems require 510(k) clearance (the FDA premarket-notification pathway demonstrating substantial equivalence to a legally marketed device). Root canal therapy is the long-established standard for non-vital tooth preservation.
Cost and accessibility: Root canal therapy plus crown costs $1,500–$3,500 in the U.S.; ceramic implant plus crown costs $4,500–$8,500. Insurance typically covers root canal more fully than implants — and because institutional payers (private insurers, national health systems) face systematically lower per-tooth costs from preserving rather than replacing teeth, payers have a structural financial incentive to favor root canal therapy in coverage policy and, indirectly, in the funding of clinical guideline development and comparative-effectiveness research. Ceramic implants are less widely available than titanium; ceramic-implant-experienced surgeons cluster in larger metropolitan areas and certain integrative-dentistry practices.
Decision tree complexity: The choice is rarely a clean either/or. Tooth restorability, bone volume, patient preference for metal-free care, tolerance for surgical recovery, cost considerations, and practitioner availability all enter the decision. Second opinions — including from both an endodontist and a biological dentist — are commonly sought for borderline cases.

Interaction with Foundational Habits

Sleep: Direct interaction is minimal. Sleep bruxism (a parafunctional habit during sleep) bidirectionally interacts with both interventions: untreated nocturnal grinding accelerates failure of endodontically treated teeth and increases ceramic-implant fracture risk. A nightguard is the standard mitigation. Improving sleep quality reduces sleep-bruxism intensity in some studies.
Nutrition: Adequate protein intake (~1.0–1.2 g/kg/day) and micronutrient status — specifically vitamin D (target 25-OH-D >40 ng/mL), vitamin K2, calcium, and vitamin C — support bone healing for ceramic implant osseointegration and periapical bone repair after root canal. A nutrient-dense whole-food diet aligns with both Weston Price’s original observations on dental health and modern evidence on wound healing. Low refined-sugar intake reduces ongoing caries and periodontal-disease activity that would jeopardize either intervention.
Exercise: Regular aerobic and resistance exercise improves bone density and may modestly improve implant osseointegration outcomes. Heavy contact sports should be avoided in the immediate post-implant period; a custom mouthguard is appropriate for ongoing combat or contact-sport participation regardless of which intervention was chosen.
Stress management: Chronic stress upregulates cortisol and inflammatory cytokines, impairs wound healing, and increases bruxism intensity — affecting outcomes of both procedures. Mind-body practices (meditation, breathwork) and adequate sleep reduce stress-mediated dental complications. Stress-related immunosuppression also adversely affects post-procedure healing for either pathway.

Monitoring Protocol & Defining Success

The following parameters should be measured before initiating either intervention and at defined intervals afterward to detect failure early. Baseline values establish individualized targets for healing.

Biomarker	Optimal Functional Range	Why Measure It?	Context/Notes
25-Hydroxyvitamin D (25-OH-D)	40–80 ng/mL	Bone-healing capacity for both extraction socket and periapical repair	Functional range exceeds the conventional sufficiency threshold of >30 ng/mL; non-fasting; test 3 months pre-procedure
HbA1c (glycated hemoglobin)	<5.7% (ideal); <7% (acceptable)	Glycemic control predicts implant osseointegration and periapical healing	Functional range is tighter than the conventional <7% diabetic target; non-fasting
hsCRP (high-sensitivity C-reactive protein, a general marker of systemic inflammation)	<1.0 mg/L	Baseline inflammatory burden; tracks reduction after successful intervention	Avoid testing during acute illness; fasting not required
Serum calcium and ionized calcium	9.5–10.2 mg/dL (total); 1.20–1.32 mmol/L (ionized)	Bone-mineral substrate availability for healing	Fasting morning sample preferred
CBC (complete blood count) with differential	Within reference; absolute neutrophils 2,500–6,000/μL	Detects underlying infection or hematologic compromise affecting healing	Routine fasting not required
Periapical radiograph (treated tooth)	Resolution of apical radiolucency by 12–24 months	Direct visualization of healing after root canal therapy	Standardized angulation; compare to pre-treatment baseline
CBCT (cone-beam computed tomography)	Reduction in periapical lesion volume; absence of cavitation at extraction site	Quantitative 3D follow-up for complex cases or unresolved symptoms	Higher radiation dose than periapical; not for routine screening
Implant marginal bone level (radiographic)	<0.2 mm change/year after first-year remodeling	Detects peri-implantitis; first year typically shows 1.0–1.5 mm physiologic remodeling	Standardized periapical with positioning device
Probing depth around ceramic implant	≤4 mm; no bleeding on probing	Soft-tissue health and early peri-implantitis detection	Six sites per implant; performed by hygienist at recall

Ongoing monitoring schedule: Periapical radiograph at 6 months, 1 year, 2 years post-root-canal, then every 2–3 years for life. For ceramic implants: clinical and radiographic exam at 1 month, 3 months, 6 months, 1 year post-placement, then every 6–12 months. Soft-tissue probing every 6–12 months for ceramic implants.

Qualitative markers:

Absence of symptoms — no spontaneous pain, no pain on biting, no temperature sensitivity for the treated tooth or implant
Functional comfort — confident chewing without discomfort or pressure sensation
Aesthetic satisfaction — patient acceptance of crown color, contour, and gingival appearance
Soft-tissue health — pink, firm gingival tissue without bleeding, swelling, or fistula
Systemic energy and inflammatory load reduction — qualitative tracking of fatigue, joint stiffness, or unexplained inflammatory symptoms in patients who pursued extraction for systemic reasons (subjective; complements quantitative biomarker tracking)

Emerging Research

Long-term ceramic implant RCTs: The NCT05326880 5-year RCT comparing two-piece zirconia (Straumann PURE) with titanium implants (60 patients, recruiting) will provide the strongest head-to-head medium-term comparison to date.
Practice-based zirconia evidence: The NCT06314425 prospective case series of SDS zirconia implants (100 patients, active not recruiting) examines extraction-and-immediate-placement outcomes, the protocol most relevant to patients pursuing the biological-dentistry pathway.
Five-year PMCF (Post-Market Clinical Follow-up) on one-piece vs. two-piece ceramic: NCT06287346 (652 patients, recruiting) compares one-piece and two-piece ceramic-implant survival — addressing the unresolved question of which design pattern offers the best long-term outcome for the metal-free pathway.
Endodontic systemic-health biomarker work: The 2025 Zhang et al. metabolomic study (Successful Endodontic Treatment Improves Glucose and Lipid Metabolism) is the most robust evidence yet that successful root canal treatment shifts systemic metabolite profiles favorably. Replication and head-to-head comparison with extraction outcomes is the key next step.
Cardiovascular biomarker studies post-treatment: Al-Abdulla et al. 2023 (Successful Endodontic Treatment Reduces Serum Levels of Cardiovascular Disease Risk Biomarkers) documented significant 2-year reductions in hsCRP, asymmetric dimethylarginine, and matrix metalloprotease-2 after successful endodontic retreatment. The unresolved question is whether extraction-plus-implant achieves equal, lesser, or greater systemic improvement.
Future directions strengthening the case for ceramic implants: RCTs directly comparing extraction-plus-ceramic-implant with successful root canal on systemic inflammatory and metabolic outcomes; long-term (15+ year) follow-up of two-piece zirconia systems; head-to-head peri-implantitis incidence data versus titanium.
Future directions strengthening the case for root canal preservation: Continued biomarker improvements with refined obturation materials and laser/ozone disinfection adjuncts; trials of regenerative endodontic therapy (revitalizing the dental pulp rather than obturating the canal) which would address the “dead tooth” critique fundamentally.
Cavitation/NICO research: Controlled epidemiological studies of cavitation-lesion prevalence at extraction sites and their association (or lack thereof) with systemic symptoms remain the principal evidence gap separating mainstream and biological-dentistry interpretations of the extraction-plus-implant pathway.

Conclusion

The choice between ceramic implant after extraction and root canal preservation of a non-vital tooth is one of the most contested decisions in modern dentistry. Both pathways now carry substantial long-term clinical data: contemporary zirconia implants demonstrate high long-term survival with osseointegration and tooth-colored aesthetics, while well-performed root canal therapy preserves natural tooth structure and is associated with reduced serum inflammatory markers and improved metabolic profiles when successful.

The contested ground is whether residual anaerobic bacteria in the dentinal tubules of root-canal-treated teeth maintain a low-grade systemic inflammatory burden that complete extraction would remove. The endodontic literature emphasizes the biomarker improvements after successful treatment; the biological-dentistry community, organized through dedicated professional bodies, treats the residual-bacteria concern as an active clinical reality and prefers extraction with thorough socket debridement plus ceramic implant. Both positions reflect structural financial interests — endodontists earn from preservation, ceramic-implant clinicians from replacement, and institutional payers tend to favor the lower-cost preservation path — and these conflicts apply on all sides of the debate.

For longevity-oriented adults the decision is highly individualized: tooth restorability, pre-existing inflammatory burden, metal sensitivity, bone volume, and willingness to undergo more extensive surgery all weigh meaningfully. The systemic-inflammation signal carries weight in either direction, with the relative scale of benefit between the two pathways differing by individual case rather than being uniformly settled.

Top - Benefits - Risks - Protocol

Ceramic Implants vs. Root Canals for Health & Longevity

Motivation

Recommended Reading

Grokipedia

Examine

ConsumerLab

Systematic Reviews

Mechanism of Action

Historical Context & Evolution

Expected Benefits

High 🟩 🟩 🟩

Tooth Retention with Bone and Proprioception Preservation (Root Canal)

Long-Term Survival of Ceramic Implants (Ceramic Implant)

Reduction in Systemic Inflammatory Burden (Both, When Successful)

Medium 🟩 🟩

Avoidance of Metal Hypersensitivity and Galvanic Effects (Ceramic Implant)

Lower Bacterial Affinity and Reduced Peri-Implant Inflammation (Ceramic Implant)

Aesthetic Outcomes in the Visible Zone (Ceramic Implant)

Low 🟩

Cost-Effectiveness Over Lifetime (Root Canal)

Speculative 🟨

Reduction in Chronic Disease Burden via Elimination of Anaerobic Reservoir (Ceramic Implant After Extraction)

Improved Glycemic and Cardiovascular Markers Beyond What Successful Root Canal Achieves (Ceramic Implant After Extraction)

Benefit-Modifying Factors

Potential Risks & Side Effects

High 🟥 🟥 🟥

Persistent or Recurrent Apical Infection After Root Canal (Root Canal)

Implant Failure Including Early Osseointegration Failure (Ceramic Implant)

Medium 🟥 🟥

Vertical Root Fracture and Crown Failure of Endodontically Treated Teeth (Root Canal)

Peri-Implantitis and Marginal Bone Loss (Ceramic Implant)

Surgical Risks of Extraction and Implant Placement (Ceramic Implant)

Low 🟥

Bacteremia and Transient Inflammatory Spikes During Procedure (Both)

Implant Fracture Due to Material Brittleness (Ceramic Implant)

Speculative 🟨

Cavitation/Jawbone Osteonecrosis at Extraction Site (Ceramic Implant Path) ⚠️ Conflicted

Tooth Loss and Cardiovascular Mortality (Ceramic Implant Path)

Risk-Modifying Factors

Key Interactions & Contraindications

Risk Mitigation Strategies

Therapeutic Protocol

Discontinuation & Cycling

Sourcing and Quality

Practical Considerations

Interaction with Foundational Habits

Monitoring Protocol & Defining Success

Emerging Research

Conclusion